PRUSHA CONNORS: Open Payments
NPI 1265880082 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$455 in 14 payments from 7 companies in 2025. Trend: 2023 $289 · 2024 $563 · 2025 $455
Food & beverage: $455
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 3 | $181 |
| Galderma Laboratories, L.P. | 4 | $103 |
| Janssen Biotech, Inc. | 2 | $40 |
| Novartis Pharmaceuticals Corporation | 2 | $39 |
| Organon LLC | 1 | $32 |
| ABBVIE INC. | 1 | $31 |
| Abbott Laboratories | 1 | $30 |
Products named: Bimzelx, TREMFYA, XOLAIR, VTAMA, SUPERA, DYSPORT.
Industry payments across CA — which companies pay providers there.
